What is Clinical Trials?
Based in St. Louis, Arch Clinical Trials operates as a physician-owned practice dedicated to advancing medical science through rigorous clinical research. The company specializes in high-stakes therapeutic areas, including Bipolar Disorder, Depression, and Alzheimer's disease. By providing cost-effective, reliable data solutions, the firm bridges the gap between complex medical research requirements and the need for efficient, patient-centric trial execution. Their model emphasizes expert care and deep market knowledge, making them a preferred partner for sponsors navigating the complexities of mental health drug development.
How much funding has Clinical Trials raised?
Clinical Trials has raised a total of $95K across 1 funding round:
Debt
$95K
Debt (2021): $95K with participation from PPP
Key Investors in Clinical Trials
PPP
Public-Private Partnership
What's next for Clinical Trials?
With the successful acquisition of this latest investment, Arch Clinical Trials is poised to enter a new phase of operational maturity. The company is expected to focus on expanding its trial site footprint and enhancing its technological infrastructure to support more complex, multi-center studies. As the demand for specialized mental health research continues to rise, the firm's ability to provide high-quality, compliant data will be critical in maintaining its competitive edge. Future strategic efforts will likely center on deepening partnerships with global pharmaceutical entities and optimizing participant recruitment strategies to ensure the timely delivery of clinical milestones.
See full Clinical Trials company page
